Chan Yang

Guangdong Provincial Key Laboratory Of New Drug Screening
Guangzhou, 510515, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

Efavirenz Mitigates Dyslipidemia and Attenuates Ulcerative Colitis through Gut Microbiota Modulation.

Journal: ACS infectious diseases

Published: June 01, 2026

Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology.

Caspase Recruitment Domain 6 (CARD6) is the therapeutic target of dihydroartemisinin for lupus nephritis based on Proteolysis Targeting Chimera (PROTAC) technology.

Journal: British journal of pharmacology

Published: May 22, 2025

Salvianolic acid A from Salvia miltiorrhiza identified as a cap-dependent endonuclease inhibitor for pathogenic arenaviruses.

Salvianolic acid A from Salvia miltiorrhiza identified as a cap-dependent endonuclease inhibitor for pathogenic arenaviruses.

Journal: Acta pharmacologica Sinica

Published: April 14, 2025

SNX10 enhances HCoV-OC43 infection by facilitating viral entry and inhibiting virus-triggered autophagy.

SNX10 enhances HCoV-OC43 infection by facilitating viral entry and inhibiting virus-triggered autophagy.

Journal: Virologica Sinica

Published: March 22, 2025

Small molecule UCM05 inhibits HSV-2 infection via targeting viral glycoproteins and fatty acid synthase with potentiating antiviral immunity.

Small molecule UCM05 inhibits HSV-2 infection via targeting viral glycoproteins and fatty acid synthase with potentiating antiviral immunity.

Journal: Virology journal

Published: March 11, 2025

A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA-PB1 interactions and modulating host macrophage inflammation.

A novel C-3-substituted oleanolic acid benzyl amide derivative exhibits therapeutic potential against influenza A by targeting PA-PB1 interactions and modulating host macrophage inflammation.

Journal: Acta pharmaceutica Sinica. B

Published: October 20, 2024

Oxymatrine Ameliorates Lupus Nephritis by Targeting the YY1-Mediated IL-6/STAT3 Axis.

Oxymatrine Ameliorates Lupus Nephritis by Targeting the YY1-Mediated IL-6/STAT3 Axis.

Journal: International journal of molecular sciences

Published: October 15, 2024

Innovative transparent silk-melamine formaldehyde film with enhanced corrosion resistance and high tensile strength for surface decoration.

Innovative transparent silk-melamine formaldehyde film with enhanced corrosion resistance and high tensile strength for surface decoration.

Journal: International journal of biological macromolecules

Published: August 24, 2024

Amyloid-like fibrils derived from β-sheets of gp120 contribute to the neuronal pathology of HIV-associated neurocognitive disorders.

Amyloid-like fibrils derived from β-sheets of gp120 contribute to the neuronal pathology of HIV-associated neurocognitive disorders.

Journal: Acta pharmaceutica Sinica. B

Published: July 27, 2024

Antagonising Yin Yang 1 ameliorates the symptoms of lupus nephritis via modulating T lymphocyte signaling.

Antagonising Yin Yang 1 ameliorates the symptoms of lupus nephritis via modulating T lymphocyte signaling.

Journal: Pharmacological research

Published: July 20, 2024

CFTR Inhibitors Display Antiviral Activity against Herpes Simplex Virus.

CFTR Inhibitors Display Antiviral Activity against Herpes Simplex Virus.

Journal: Viruses

Published: July 19, 2024

Cdc42 improve SARS-CoV-2 spike protein-induced cellular senescence through activating of Wnt/β-Catenin signaling pathway.

Cdc42 improve SARS-CoV-2 spike protein-induced cellular senescence through activating of Wnt/β-Catenin signaling pathway.

Journal: Frontiers in cellular and infection microbiology

Published: June 15, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026